Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
about
How I treat pediatric acute myeloid leukemiaChildhood acute myeloid leukaemiaCurrent Management of Childhood Acute Myeloid Leukemia.Attitudes toward infection prophylaxis in pediatric oncology: a qualitative approachInfections in pediatric acute promyelocytic leukemia: from the Canadian infections in acute myeloid leukemia research group.Neutropenia Precautions for Children Receiving Chemotherapy or Stem Cell Transplantation for Cancer.Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.A critical review of which children with acute myeloid leukaemia need stem cell procedures.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.Invasive Aspergillosis in Children: Update on Current Guidelines
P2860
Q26992280-E280000C-E9E6-4ED4-BA86-022D309E81F0Q27005960-96C01319-4CC4-44BD-B256-721E93C4B52CQ30244036-5A013752-1DBC-42DC-A993-25E3DFDECBBBQ34462307-4BDC1CE1-D404-485B-998A-2108B899F2EEQ34756538-D51DD85A-DB90-4444-9BFE-625B2CD03BF3Q35188126-A5F9498C-9FB4-4F93-A2F6-F4FAAEC5BDB1Q36053792-00147189-1611-4168-8119-918E1F8BFDCBQ37528435-6ECC3B20-639C-400D-923C-6BBE1FD30188Q37711537-34EC6312-317A-4258-992F-A0D23B12D7E1Q38068800-40EED239-ED54-4281-BA3F-23708048DAF6Q38205864-F6BD4F15-A063-4344-9AFB-486348FB5571Q38284455-BA7AC6B3-BA4B-4180-84B5-9811AFD74B84Q38353420-FAA91D19-72A4-4C39-9790-1C0D36753EF1Q38678458-63365676-E44F-4536-9F34-656A740F2569Q38822532-51779E6C-A393-4B63-B60A-1696C6C5A588Q39002810-7ABC7921-473B-4B16-93DB-83220D2A1A11Q40194039-B16129C7-CD69-484A-8F22-2D8684AFCAEAQ41070207-74591A19-94B4-4CD8-AB18-52878AEB1B90Q41929675-D4885D2C-64B3-4910-811B-2ADB708D363EQ44133007-68C5B2F7-472A-4DD2-80AF-D766ED771DE2Q54973296-20DB5D61-6E7E-4A75-9E55-150EA46AF776Q58775551-38FF734C-E3DC-4E81-A602-A4DE4C09FCA5
P2860
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@ast
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@en
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@nl
type
label
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@ast
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@en
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@nl
prefLabel
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@ast
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@en
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@nl
P2093
P2860
P356
P1476
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
@en
P2093
Brian T Fisher
Christopher C Dvorak
Lillian Sung
Michael Nieder
Sarah Alexander
Theoklis E Zaoutis
William J Steinbach
P2860
P356
10.1002/PBC.23415
P577
2011-11-18T00:00:00Z